Overexpression of heme oxygenase-1 in coronary atherosclerosis of Japanese autopsies with diabetes mellitus: Hisayama study

Atherosclerosis

Volumn 202, Issue 2, 2009, Pages 573-581

  Song, Jingyu ^a,b   Sumiyoshi, Shinji ^a   Nakashima, Yutaka ^c   Doi, Yasufumi ^a   Iida, Mitsuo ^a   Kiyohara, Yutaka ^a   Sueishi, Katsuo ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b Yanbian University College of Basic Medicine   (Japan)

^c FUKUOKA RED CROSS HOSPITAL   (Japan)

Author keywords

Atherosclerosis; Diabetes mellitus; Heme oxygenase 1; Human coronary artery; Immunohistochemistry

Indexed keywords

CD8 ANTIGEN; HEME OXYGENASE 1;

ADULT; AGED; ANGIOGENESIS; ARTERY INTIMA; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; AUTOPSY; CELL INFILTRATION; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY ATHEROSCLEROSIS; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE CLASSIFICATION; DISEASE COURSE; ENDOTHELIUM CELL; ENZYME LOCALIZATION; FEMALE; HUMAN; HUMAN TISSUE; HYPERCHOLESTEROLEMIA; IMMUNOHISTOCHEMISTRY; INFLAMMATION; JAPANESE; MACROPHAGE; MALE; MEDICAL SOCIETY; MICROVASCULATURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SMOOTH MUSCLE FIBER; STENOSIS;

AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; AUTOPSY; CORONARY ARTERY DISEASE; CORONARY VESSELS; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HEME OXYGENASE-1; HUMANS; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MALE; MIDDLE AGED; MYOCYTES, SMOOTH MUSCLE; NEOVASCULARIZATION, PHYSIOLOGIC; RISK FACTORS;

EID: 58549089876     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2008.05.057     Document Type: Article

References (30)

1. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
2. Qiao Q., Hu G., Tuomilehto J., et al. DECODA Study Group. Age- and sex-specific prevalence of diabetes and impaired glucose regulation in 11 Asian cohorts. Diabetes Care 26 (2003) 1770-1780
3. Beckman J.A., Creager M.A., and Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 287 (2002) 2570-2625
4. Ryter S.W., Alam J., and Choi A.M.K. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev 86 (2006) 583-650
5. Morita T. Heme oxygenase and atherosclerosis. Arterioscler Thromb Vasc Biol 25 (2005) 1786-1795
6. Orozco L.D., Kapturczak M.H., Barajas B., et al. Heme oxygenase-1 expression in macrophages plays a beneficial role in atherosclerosis. Circ Res 100 (2007) 1703-1711
7. Kaneda H., Ohno M., Taguchi J., et al. Heme oxygenase-1 gene promoter polymorphism is associated with coronary artery disease in Japanese patients with coronary risk factors. Arterioscler Thromb Vasc Biol 22 (2002) 1680-1685
8. Bussolati B., Ahmed A., Pemberton H., et al. Bifunctional role for VEGF-induced heme oxygenas-1 in vivo: induction of angiogenesis and inhibition of leukocytic infiltration. Blood 103 (2004) 761-766
9. Devesa I., Ferárndiz L., Guillén I., et al. Potential role of heme oxygenase-1 in the progression of rat adjuvant arthritis. Lab Invest 85 (2005) 34-44
10. Kumamoto M., Nakashima Y., and Sueishi K. Intimal neovascularization in human coronary atherosclerosis: its origin and pathophysiological significance. Human Pathol 26 (1995) 450-456
11. Chen Y.-X., Nakashima Y., Tanaka K., et al. Immunohistochemical expression of vascular endothelial growth factor/vascular permeability factor in atherosclerotic intimas of human coronary arteries. Arterioscler Thromb Vasc Biol 19 (1999) 131-139
12. Nakano T., Nakashima Y., Yonemitsu Y., et al. Angiogenesis and lymphangiogenesis and expression of lymphangiogenic factors in the atherosclerotic intima of human coronary arteries. Human Pathol 36 (2005) 330-340
13. Ohtani K., Egashira K., Hiasa K., et al. Blockade of vascular endothelial growth factor suppresses experimental restenosis after intraluminal injury by inhibiting recruitment of monocyte lineage cells. Circulation 110 (2004) 2444-2452
14. Moreno P.R., Purushothaman K.R., Fuster V., et al. Plaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta: implications for plaque vulnerability. Circulation 110 (2004) 2032-2038
15. Virmani R., Kolodgie F.D., Burke A.P., et al. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscl Thromb Vasc Biol 25 (2005) 2054-2061
16. Wang L.-J., Lee T.-S., Lee F.-Y., et al. Expression of heme oxygenase-1 in atherosclerotic lesions. Am J Pathol 152 (1998) 711-720
17. Kubo M., Hata J., Ninomiya T., et al. A nonsynonymous SNP in PRKCH (protein kinase Cη) increases the risk of cerebral infarction. Nat Genet 39 (2007) 212-217
18. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
19. World Health Organization/International Association for the Study of Obesity/International Obesity Task Force. The Asia-Pacific perspective: redifining obesity and its treatment. Available at: http://www.diabetes.com.au/pdf/obesity_report.pdf.
20. Stary H.C., Chandler A.B., Dinsmore R.E., et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis: a report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 92 (1995) 1355-1374
21. Sumiyoshi S., Nakashima Y., Chen Y.-X., et al. Interleukin-10 expression is positively correlated with oxidized LDL deposition and inversely with T-lymphocyte infiltration in atherosclerotic intimas of human coronary arteries. Pathol Res Pract 202 (2006) 141-150
22. Sun J., Brand M., Zenke Y., et al. Heme regulates the dynamic exchange of Bach 1 and NF-E2-related factors in the Maf transcription factor network. Proc Natl Acad Sci USA 101 (2003) 1461-1466
23. Kränke G., Kadl A., Ikonomu E., et al. Expression of heme oxygenase-1 in human vascular cells is regulated by peroxisome proliferator-activated receptors. Arterioscl Thromb Vasc Biol 27 (2007) 1276-1282
24. Evans R.M., Barish G.D., and Wang Y.X. PPARs and the complex journey to obesity. Nat Med 10 (2004) 355-361
25. Wu B.J., Kathir K., Witting P.W., et al. Antioxidants protect from atherosclerosis by a heme oxygenase-1 pathway that is independent of free radical scavenging. J Exp Med 203 (2006) 1117-1127
26. Ali F., Hamdulay S.S., Kinderlerer A.R., et al. Statin-mediated cytoprotection of human vascular endothelial cells: a role for Kruppel-like factor 2-dependent induction of heme oxygenase-1. J Thromb Haemost (2007) 2537-2546
27. McGill H.C., McMahan C.A., Malcom G.T., et al. Relation of glycohemoglobin and adiposity to atherosclerosis in youth. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Arterioscler Thromb Vasc Biol 15 (1995) 431-440
28. Burke A.P., Kolodgie F.D., Zieske A., et al. Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study. Arteriocler Thromb Vasc Biol 24 (2004) 1266-1271
29. Kisanuki Y., Asada Y., Sato Y., et al. Coronary atherosclerosis in youths in Kyushu island, Japan: histological findings and stenosis. J Atheroscler Thromb 6 (2000) 55-59
30. Ninomiya T., Kubo M., Doi Y., et al. Impact of metabolic syndrome on the development of cardiovascular disease in Japanese population: the Hisayama study. Stroke 38 (2007) 2063-2069